Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Envoy Medical, Inc. - Class A Common Stock
(NQ:
COCH
)
0.7023
+0.0188 (+2.75%)
Streaming Delayed Price
Updated: 9:41 AM EDT, Apr 8, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
31,637
Open
0.7025
Bid (Size)
0.6948 (100)
Ask (Size)
0.7024 (100)
Prev. Close
0.6835
Today's Range
0.6938 - 0.7098
52wk Range
0.3625 - 1.910
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Envoy Medical Announces First Patients Successfully Reaching 12-Month Endpoint in Pivotal Clinical Trial for Fully Implanted Cochlear Implant
April 01, 2026
White Bear Lake, Minnesota--(Newsfile Corp. - April 1, 2026) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a hearing health company...
Via
Newsfile
Envoy Medical Reports Full Year 2025 Financial Results
March 23, 2026
Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing...
Via
Newsfile
Topics
Intellectual Property
Performance
YTD
+0.9%
+0.9%
1 Month
+3.4%
+3.4%
3 Month
+2.9%
+2.9%
6 Month
-55.8%
-55.8%
1 Year
-44.7%
-44.7%
More News
Read More
Envoy Medical Completes Enrollment of Pivotal Clinical Trial Evaluating First-Of-Its-Kind Fully Implanted Cochlear Implant
March 11, 2026
Via
Newsfile
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
February 24, 2026
Via
Newsfile
Envoy Medical Secures Three New Patents Strengthening Competitive Position in the Fully Implanted Hearing Space
February 23, 2026
Via
Newsfile
Topics
Intellectual Property
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial
February 19, 2026
Via
Newsfile
Envoy Medical Nears Completion of Enrollment in Pivotal Clinical Trial of Fully Implanted Acclaim(R) Cochlear Implant
February 17, 2026
Via
Newsfile
Envoy Medical Announces Closing of Up to $78.0 Million Upsized Public Offering
February 12, 2026
Via
Newsfile
These stocks have an unusual volume in today's session
↗
February 12, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
February 12, 2026
Via
Chartmill
Which stocks are experiencing notable movement on Wednesday?
↗
February 11, 2026
Via
Chartmill
Top stock movements in today's session.
↗
February 11, 2026
Via
Chartmill
Envoy Medical Announces Pricing of Up to $78.0 Million Upsized Public Offering
February 11, 2026
Via
Newsfile
Small Cap Growth Virtual Investor Conference: Presentations Now Available for On-Demand Viewing
February 06, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Small Cap Growth Virtual Investor Conference Agenda Announced for February 5th
February 02, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Envoy Medical to Present at the Small Cap Growth Virtual Investor Conference February 5
January 29, 2026
From
Virtual Investor Conferences
Via
GlobeNewswire
Envoy Medical Reaches Enrollment Milestone in Pivotal Clinical Study of Fully Implanted Acclaim(R) Cochlear Implant
December 18, 2025
Via
Newsfile
Envoy Medical Secures New Australian Patent for Cochlear Implant Innovation Aimed at Enhancing Input Signal-to-Noise Ratio
December 16, 2025
Via
Newsfile
Topics
Intellectual Property
Envoy Medical Completes First Set of Activations in Final Stage of Pivotal Clinical Study for its First-Of-Its-Kind Fully Implanted Acclaim(R) Cochlear Implant
December 10, 2025
Via
Newsfile
Envoy Medical to Host Fireside Chat with CEO Brent Lucas and the First Acclaim(R) Cochlear Implant Patient
December 04, 2025
Via
Newsfile
Envoy Medical Announces the Grant of Its 40th U.S. Patent
December 02, 2025
Via
Newsfile
Topics
Intellectual Property
Envoy Medical Secures New U.S. Patent for Innovative Cochlear Implant System Featuring a Removable Earplug Sensor and an Implanted Battery
November 20, 2025
Via
Newsfile
Topics
Intellectual Property
Envoy Medical Achieves Six-Month Milestone with First 10 Patients in Acclaim(R) Cochlear Implant Clinical Trial
November 18, 2025
Via
Newsfile
Topics
Intellectual Property
Envoy Medical Reports Third Quarter 2025 Financial and Operational Results
November 10, 2025
Via
Newsfile
Topics
Intellectual Property
Envoy Medical Announces First Three Patients Enrolled in Final Stage of Acclaim(R) Cochlear Implant Pivotal Clinical Trial
November 04, 2025
Via
Newsfile
Frequently Asked Questions
Is Envoy Medical, Inc. - Class A Common Stock publicly traded?
Yes, Envoy Medical, Inc. - Class A Common Stock is publicly traded.
What exchange does Envoy Medical, Inc. - Class A Common Stock trade on?
Envoy Medical, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Envoy Medical, Inc. - Class A Common Stock?
The ticker symbol for Envoy Medical, Inc. - Class A Common Stock is COCH on the Nasdaq Stock Market
What is the current price of Envoy Medical, Inc. - Class A Common Stock?
The current price of Envoy Medical, Inc. - Class A Common Stock is 0.7023
When was Envoy Medical, Inc. - Class A Common Stock last traded?
The last trade of Envoy Medical, Inc. - Class A Common Stock was at 04/08/26 09:41 AM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
